Immune Characterization of the HBHA-specific Response in Mycobacterium Tuberculosis-infected Patients with or Without HIV Infection

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Aug 25

PMID 28837654

Citations 16

Authors

Teresa Chiacchio

Giovanni Delogu

Valentina Vanini

Gilda Cuzzi

Flavio De Maio

Carmela Pinnetti

Alessandro Sampaolesi

Andrea Antinori

Delia Goletti

Affiliations

Soon will be listed here.

Abstract

Introduction: RD1-based Interferon-γ Release Assays (IGRAs) cannot distinguish latent from active tuberculosis (TB) disease. Conversely, a positive response to heparin-binding haemagglutinin (HBHA)-based IGRAs, among TB-infected subjects, correlates with Mycobacterium tuberculosis (Mtb) containment and low risk of TB progression. The aim of this study was to characterize HBHA-immune responses in HIV-infected and uninfected subjects with active TB or latent TB infection (LTBI).

Methods: 49 subjects were prospectively enrolled: 22 HIV-uninfected (13 TB, 9 LTBI) and 27 HIV-infected (12 HIV-TB, 15 HIV-LTBI). Whole blood and peripheral blood mononuclear cells were stimulated with HBHA and RD1 antigens. Interferon (IFN)γ release was evaluated by ELISA whereas cytokine profile [IFNγ, tumor necrosis (TNF)α, interleukin (IL)2] and phenotype (CD45RA, CCR7) by flow cytometry.

Results: Among LTBI individuals, HBHA stimulation induced IFNγ release in all the HIV-uninfected, while, only 4/15 HIV-infected responded. Within the active TB, only 5/13 HIV-uninfected and 1/12 HIV-TB patients responded. Interestingly, by cytometry we showed that CD4+ T-cells response to HBHA was significantly impaired in the HIV-infected subjects with TB or LTBI compared to the HIV-uninfected subjects. The phenotype of HBHA-specific CD4 T-cells showed a predominantly central memory (CM) and effector memory (EM) phenotype without differences among the groups. Differently, HBHA-specific CD8+ T-cells, showed mainly a CM and naïve phenotype in LTBI group while TB, HIV-LTBI and HIV-TB groups were characterized by EM or terminally differentiated phenotypes. Interestingly, differently than what observed for RD1, the cytokine profile of HBHA-specific T-cells evaluated by cytometry showed that the CD4+ T-cells were mostly monofunctional. Conversely, CD8-specific T-cells were mostly monofunctional for both HBHA and RD1 stimulations.

Conclusions: These results characterize the impact of HIV infection in CD4- and CD8-specific response to HBHA in both LTBI and TB patients. HIV infection impairs the CD4 response to HBHA and likely this may lead to an impairment of TB control.

Citing Articles

HBHA induces IL-10 from CD4+ T cells in patients with active tuberculosis but IFN-γ and IL-17 from individuals with infection.

Izumida M, Jobe H, Coker E, Barry A, Rashid M, Manneh I Front Immunol. 2024; 15:1422700.

PMID: 39257584 PMC: 11384583. DOI: 10.3389/fimmu.2024.1422700.

Identification of cytokine signatures in HIV‑infected individuals with and without co‑infection.

Indrati A, Sumarpo A, Haryanto J, Rosmiati N, Munaya S, Turbawaty D Biomed Rep. 2024; 21(3):131.

PMID: 39070110 PMC: 11273192. DOI: 10.3892/br.2024.1819.

C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay.

Russomando G, Sanabria D, Diaz Acosta C, Rojas L, Franco L, Arenas R Front Immunol. 2024; 15:1308015.

PMID: 38545118 PMC: 10967656. DOI: 10.3389/fimmu.2024.1308015.

Opti-4TB: A protocol for a prospective cohort study evaluating the performance of new biomarkers for active tuberculosis outcome prediction.

Bahuaud O, Genestet C, Hoffmann J, Dumitrescu O, Ader F Front Med (Lausanne). 2022; 9:998972.

PMID: 36186786 PMC: 9515406. DOI: 10.3389/fmed.2022.998972.

In-Depth Immunophenotyping With Mass Cytometry During TB Treatment Reveals New T-Cell Subsets Associated With Culture Conversion.

Chedid C, Andrieu T, Kokhreidze E, Tukvadze N, Biswas S, Ather M Front Immunol. 2022; 13:853572.

PMID: 35392094 PMC: 8980213. DOI: 10.3389/fimmu.2022.853572.

References

Temmerman S, Place S, Debrie A, Locht C, Mascart F . Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis. J Infect Dis. 2005; 192(2):226-32. DOI: 10.1086/430930. View

Wyndham-Thomas C, Corbiere V, Dirix V, Smits K, Domont F, Libin M . Key role of effector memory CD4+ T lymphocytes in a short-incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis. Clin Vaccine Immunol. 2014; 21(3):321-8. PMC: 3957667. DOI: 10.1128/CVI.00651-13. View

Zanetti S, Bua A, Delogu G, Pusceddu C, Mura M, Saba F . Patients with pulmonary tuberculosis develop a strong humoral response against methylated heparin-binding hemagglutinin. Clin Diagn Lab Immunol. 2005; 12(9):1135-8. PMC: 1235805. DOI: 10.1128/CDLI.12.9.1135-1138.2005. View

Lewinsohn D, Heinzel A, Gardner J, Zhu L, Alderson M, Lewinsohn D . Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells. Am J Respir Crit Care Med. 2003; 168(11):1346-52. DOI: 10.1164/rccm.200306-837OC. View

Diedrich C, Flynn J . HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis?. Infect Immun. 2011; 79(4):1407-17. PMC: 3067569. DOI: 10.1128/IAI.01126-10. View

Beveridge N, Fletcher H, Hughes J, Pathan A, Scriba T, Minassian A . A comparison of IFNgamma detection methods used in tuberculosis vaccine trials. Tuberculosis (Edinb). 2008; 88(6):631-40. DOI: 10.1016/j.tube.2008.06.005. View

Masungi C, Temmerman S, Van Vooren J, Drowart A, Pethe K, Menozzi F . Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J Infect Dis. 2002; 185(4):513-20. DOI: 10.1086/338833. View

Launois P, Drowart A, Bourreau E, Couppie P, Farber C, Van Vooren J . T cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections. Clin Dev Immunol. 2010; 2011. PMC: 2948887. DOI: 10.1155/2011/640309. View

Wilkinson K, Wilkinson R . Polyfunctional T cells in human tuberculosis. Eur J Immunol. 2010; 40(8):2139-42. DOI: 10.1002/eji.201040731. View

10.

Houben R, Crampin A, Ndhlovu R, Sonnenberg P, Godfrey-Faussett P, HAAS W . Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection. Int J Tuberc Lung Dis. 2011; 15(1):24-31. View

11.

Mack U, Migliori G, Sester M, Rieder H, Ehlers S, Goletti D . LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009; 33(5):956-73. DOI: 10.1183/09031936.00120908. View

12.

Vanini V, Petruccioli E, Gioia C, Cuzzi G, Orchi N, Rianda A . IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J Infect. 2012; 65(1):49-59. DOI: 10.1016/j.jinf.2012.03.017. View

13.

Caccamo N, Guggino G, Joosten S, Gelsomino G, Di Carlo P, Titone L . Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol. 2010; 40(8):2211-20. DOI: 10.1002/eji.201040455. View

14.

Getahun H, Matteelli A, Abubakar I, Abdel Aziz M, Baddeley A, Barreira D . Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J. 2015; 46(6):1563-76. PMC: 4664608. DOI: 10.1183/13993003.01245-2015. View

15.

Stylianou E, Diogo G, Pepponi I, van Dolleweerd C, Arias M, Locht C . Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice. Eur J Immunol. 2013; 44(2):440-9. DOI: 10.1002/eji.201343887. View

16.

Harari A, Rozot V, Bellutti Enders F, Perreau M, Mazza Stalder J, Nicod L . Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med. 2011; 17(3):372-6. PMC: 6570988. DOI: 10.1038/nm.2299. View

17.

Petruccioli E, Chiacchio T, Pepponi I, Vanini V, Urso R, Cuzzi G . First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus. J Infect. 2016; 73(6):588-597. DOI: 10.1016/j.jinf.2016.09.008. View

18.

Pokrovskiy V . HIV epidemic in Russia and neighbouring countries. J Int AIDS Soc. 2014; 17(4 Suppl 3):19502. PMC: 4224896. DOI: 10.7448/IAS.17.4.19502. View

19.

Petruccioli E, Petrone L, Vanini V, Sampaolesi A, Gualano G, Girardi E . IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis. J Infect. 2013; 66(6):475-86. DOI: 10.1016/j.jinf.2013.02.004. View

20.

Day C, Mkhwanazi N, Reddy S, Mncube Z, van der Stok M, Klenerman P . Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons. J Infect Dis. 2008; 197(7):990-9. PMC: 5688849. DOI: 10.1086/529048. View